Insider · CIK 0001816207

Call Matthew

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816207

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−136K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−147K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−17.1K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−66.2K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−41.7K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.U Disposition from Tender	Chief Operating Officer	UDisposition from Tender	−162K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−9,063 sh	—	—	0
2025-03-07	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+145K sh	—	—	145,000
2025-03-07	iTeos Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+24K sh	—	—	161,898
2024-03-07	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+225K sh	—	—	225,000
2023-12-05	iTeos Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+44K sh	—	—	137,898
2023-03-28	iTeos Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−40.2K sh	—	—	107,864
2023-03-28	iTeos Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+40.2K sh	$2.95	+$119K	93,898
2023-03-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+130K sh	—	—	130,000
2022-03-11	iTeos Therapeutics, Inc.Option (right to buy)A Award	Chief Operating Officer	AAward	+85K sh	—	—	85,000
2021-07-30	iTeos Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−53.7K sh	—	—	148,090
2021-07-30	iTeos Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+53.7K sh	$2.95	+$158K	53,672
2021-06-24	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+72K sh	—	—	72,000
2021-03-01	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+72K sh	—	—	72,000

Recent filings

Accepted (ET)
Aug 294
Call Matthew0000950170-25-112241
SEC(opens sec.gov)
Mar 114
Call Matthew0000950170-25-037520
SEC(opens sec.gov)
Mar 84
Call Matthew0000950170-24-028859
SEC(opens sec.gov)
Dec 74
Call Matthew0000950170-23-068902
SEC(opens sec.gov)
Mar 294
Call Matthew0001209191-23-021566
SEC(opens sec.gov)
Mar 104
Call Matthew0001209191-23-018014
SEC(opens sec.gov)
Mar 144
Call Matthew0001209191-22-018666
SEC(opens sec.gov)
Aug 54
Call Matthew0001209191-21-050063
SEC(opens sec.gov)
Jun 254
Call Matthew0000899243-21-026086
SEC(opens sec.gov)
Mar 34
Call Matthew0000899243-21-009376
SEC(opens sec.gov)

Companies

iTeos Therapeutics, Inc.Chief Operating Officer

Address

C/O ITEOS THERAPEUTICS, INC. 321 ARSENAL STREET

WATERTOWN, MA, 02472